Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Although the guidelines of the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative indicate that autogenous arteriovenous fistulae are the preferred type of hemodialysis ...